28 September 2017 | Statement

Georgia on the frontlines of tackling drug-resistant tuberculosis — a photo story

(Image: Mzia Lekveishvili/Unitaid)

Georgia continues to struggle with tuberculosis (TB), today’s leading infectious disease killer, and its drug-resistant forms. The homeless, unemployed, migrants, prisoners, and people who excessively consume alcohol are among the most affected. But the good news is that the number of people suffering from drug-resistant TB has dropped over the past few years largely due to the arrival of new medicines. The first drugs to be developed in almost half a century — bedaquiline and delamanid — now offer the opportunity to treat multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) more quickly and effectively.

View All News

Featured News

18 October 2017

Unitaid-led working group will study how to fight antimicrobial resistance through access to innovative treatments and diagnostics

Read More

13 October 2017

Unitaid joins Call to Action on antimicrobial resistance in Berlin

Read More

Sign Up for Unitaid Updates

  • This field is for validation purposes and should be left unchanged.